Importantly, CEACAM6 plays important roles in modulating ECM-cell adhesion leading to anoikis chemo-resistance, immune suppression, and mitochondrial metabolic defects in PDA. This evidence concerns the gene CEACAM6 and Patent ductus arteriosus.